GLENMARK PHARMACEUTICALS LTD.
| Report Date | Research house | Description | Reco | At Price | Target Price | UpSide
/DownSide | Download |
|
15-Feb-22
|
Emkay Global
|
Glenmark Pharmaceuticals reported revenue growth of 13.9% YoY (+0..
|
ACCUMULATE
|
478
|
547
|
14.44
|
|
|
14-Feb-22
|
Isec
|
Launches, margins sustainability to hold key…
|
Hold
|
485
|
550
|
13.4
|
|
|
17-Nov-21
|
KR Choksey
|
Glenmark Pharmaceuticals reported revenue growth of 6.6% YoY (+6...
|
ACCUMULATE
|
517
|
547
|
5.8
|
|
|
16-Aug-21
|
Motilal Oswal
|
In-line 1QFY22; DF drives overall earnings growth
|
Neutral
|
570
|
600
|
5.26
|
|
|
16-Aug-21
|
Isec
|
Q1 growth driven by India business…
|
Buy
|
575
|
680
|
18.26
|
|
asdsa
Upcoming Events and Recent Updates
|
11-Feb-25
|
Post ITs (Interesting Article)
-
( updated on
Feb 11 2025)
|